Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease

被引:14
作者
Kalinski, T
Krueger, S
Pelz, AF
Wieacker, P
Hartig, R
Röpke, M
Schneider-Stock, R
Dombrowski, F
Roessner, A
机构
[1] Otto Von Guericke Univ, Dept Pathol, D-39120 Magdeburg, Germany
[2] Otto Von Guericke Univ, Dept Human Genet, D-39120 Magdeburg, Germany
[3] Otto Von Guericke Univ, Dept Immunol, D-39120 Magdeburg, Germany
[4] Otto Von Guericke Univ, Dept Orthoped, D-39120 Magdeburg, Germany
关键词
cell line; secondary chondrosarcoma; Ollier's disease;
D O I
10.1007/s00428-004-1194-y
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The permanent human cell line C3842 was established from a secondary chondrosarcoma in a typical case of Ollier's disease. In the present study, we analyzed the morphological, cytogenetic and molecular biological characteristics of the cultured cells in comparison with the original tumor and investigated the invasion properties of the tumor model using functional imaging of proteolysis, matrigel assay and chick chorioallantoic membrane assay. C3842 cells exhibit the typical features of malignant cartilage tumor cells in vitro, including the expression of collagen types II, IX, XI and aggrecan. The proteolytic ability of C3842 cells is attributed to the expression of several proteases, such as cathepsin B, urokinase plasminogen activator and matrix-metalloproteinase-2, which enable the cells to degrade collagen type I and to permeate matrigel matrix. In accordance with the biological features in vivo, C3842 cells are not able to invade through the epithelium of the chick chorioallantoic membrane. In conclusion, the cell line C3842 provides the first model of a secondary chondrosarcoma in Ollier's disease in vitro, which is characterized by distinct features of such malignant cartilage tumors.
引用
收藏
页码:287 / 299
页数:13
相关论文
共 44 条
  • [1] Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas
    Aigner, T
    Müller, S
    Neureiter, D
    Illstrup, DM
    Kirchner, T
    Björnsson, J
    [J]. CANCER, 2002, 94 (08) : 2273 - 2281
  • [2] Aigner T, 1997, AM J PATHOL, V150, P2133
  • [3] Bertoni F., 2002, WHO CLASSIFICATION T, P247
  • [4] Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma
    Bovée, JVMG
    van Royen, M
    Bardoel, AFJ
    Rosenberg, C
    Cornelisse, CJ
    Cleton-Jansen, AM
    Hogendoorn, PCW
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (05) : 1587 - 1595
  • [5] Malignant progression in multiple enchondromatosis (Ollier's disease):: An autopsy-based molecular genetic study
    Bovée, JVMG
    van Roggen, JFG
    Cleton-Jansen, AM
    Taminiau, AHM
    van der Woude, HJ
    Hogendoorn, PCW
    [J]. HUMAN PATHOLOGY, 2000, 31 (10) : 1299 - 1303
  • [6] BIOLOGIC AND CLINICAL-SIGNIFICANCE OF CYTOGENETIC AND MOLECULAR CYTOGENETIC ABNORMALITIES IN BENIGN AND MALIGNANT CARTILAGINOUS LESIONS
    BRIDGE, JA
    BHATIA, PS
    ANDERSON, JR
    NEFF, JR
    [J]. CANCER GENETICS AND CYTOGENETICS, 1993, 69 (02) : 79 - 90
  • [7] BUDOWLE B, 1991, AM J HUM GENET, V48, P137
  • [8] Characterization of a newly established human chondrosarcoma cell line, CS-OKB
    Chano, T
    Okabe, H
    Saeki, Y
    Ishizawa, M
    Matsumoto, K
    Hukuda, S
    [J]. VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1998, 432 (06): : 529 - 534
  • [9] Expression of cartilage extracellular matrix and potential regulatory genes in a new human chondrosarcoma cell line
    Chansky, H
    Robbins, JR
    Cha, S
    Raskind, WH
    Conrad, EU
    Sandell, LJ
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 1998, 16 (05) : 521 - 530
  • [10] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2